For example, independent studies have reported the efficacy of p53 inhibitors in promoting neuroprotection against age-associated neurodegenerative diseases (Culmsee et al., 2001; Duan et al., 2002; Zhu et al., 2002). Here, TP53 is linked to neurodegenerative disease.